The Economic Benefits of Detecting Liver Disease Early
A look at how early detection of liver disease can significantly decrease costs while enhancing care quality and outcomes.
A look at how early detection of liver disease can significantly decrease costs while enhancing care quality and outcomes.
Exploring the recent shift in NAFLD guidelines and why redefining the condition as MASLD has broader implications for providers and patients.
Learn why addressing MASH, liver disease in an earlier stage, is crucial for improving patient outcomes and reducing healthcare costs.
Lisa Meyer MSN, RN, NI-BC, shares insights on improving patient throughput, tackling capacity challenges with early detection, and more.
Raghu Pillai shares how early disease detection impacts patient and provider engagement, plus insights on personalized care strategies.
Michelle Fortune shares valuable perspectives on the evolving landscape of cancer screening, the challenges of increased demand for screenings, and the important role of early disease detection in building long-term relationships with patients and families.
Alejandro Reti, MD, shares perspectives on managing long-term care costs, the importance of predictability in healthcare costs, and more.
Let's go beyond traditional health awareness efforts, like nostalgic billboards urging lung cancer screenings, to combat pervasive diseases.
Exploring recent developments for AFib management, from newly investigated pharmacological treatments to novel screening modalities.
Why early stroke detection matters, and the opportunity for provider organizations to improve both outcomes and financial yield.